Literature DB >> 15123994

Hypertrophic cardiomyopathy.

Steve R Ommen1, Rick A Nishimura.   

Abstract

Hypertrophic cardiomyopathy is a fascinating disease of marked heterogeneity. Hypertrophic cardiomyopathy was originally characterized by massive myocardial hypertrophy in the absence of known cause, a dynamic left ventricular outflow obstruction, and increased risk of sudden death. It is now well accepted that multiple mutations in genes encoding for the cardiac sarcomere are responsible for the disease. Complex morphologic and pathophysiological differences, disparate natural history studies, and novel treatment strategies underscore the challenge to the practicing cardiologist when faced with the management of the patient with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Year:  2004        PMID: 15123994     DOI: 10.1016/j.cpcardiol.2004.01.001

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  11 in total

1.  Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.

Authors:  Douglas L Miller; Chunyan Dou; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2014-03-06       Impact factor: 2.998

2.  Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.

Authors:  Douglas L Miller; Chunyan Dou; Xiaofang Lu; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2015-04-15       Impact factor: 2.998

3.  Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.

Authors:  Cordula M Wolf; Ivan P G Moskowitz; Scott Arno; Dorothy M Branco; Christopher Semsarian; Scott A Bernstein; Michael Peterson; Michael Maida; Gregory E Morley; Glenn Fishman; Charles I Berul; Christine E Seidman; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

4.  Surgical management of hypertrophic cardiomyopathy in 2007: what is new?

Authors:  Morgan L Brown; Hartzell V Schaff
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

5.  Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.

Authors:  Christopher J McLeod; J Martijn Bos; Jeanne L Theis; William D Edwards; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2009-10-03       Impact factor: 4.749

6.  Survival and clinical behavior of hypertrophic cardiomyopathy in a latin american cohort in contrast to cohorts from the developed world.

Authors:  Nilda Espinola-Zavaleta; Antonio Vega; Diego Martínez Basto; Ana Cecilia Alcantar-Fernández; Veronica Guarner Lans; María Elena Soto
Journal:  J Cardiovasc Ultrasound       Date:  2015-03-30

Review 7.  The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy.

Authors:  Rong Luo; Xiaoping Li; Yuequn Wang; Yongqing Li; Yun Deng; Yongqi Wan; Zhigang Jiang; Wei Hua; Xiushan Wu
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

8.  Left ventricular filling pressure assessed by exercise TDI was correlated with early HFNEF in patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  Guodong Ma; Ming Xu; Wei Gao; Zhaoping Li; Weihong Li; Baoxia Chen; Jieli Feng; Hongyan Wang; Wenying Ma; Hui Chen; Aidong Shen; Xinheng Feng; Yongzhen Zhang
Journal:  BMC Cardiovasc Disord       Date:  2014-12-18       Impact factor: 2.298

9.  Left ventricular long-axis function in hypertrophic cardiomyopathy - Relationships between e`, early diastolic excursion and duration, and systolic excursion.

Authors:  Roger E Peverill; Bon Chou; Lesley Donelan; Wai-Ee Thai
Journal:  PLoS One       Date:  2020-10-07       Impact factor: 3.240

10.  Multiple ultrasound cavitation-enabled treatments for myocardial reduction.

Authors:  Douglas L Miller; Xiaofang Lu; Chunyan Dou; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  J Ther Ultrasound       Date:  2017-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.